Compare NTHI & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTHI | ACU |
|---|---|---|
| Founded | 2008 | 1867 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 160.6M |
| IPO Year | N/A | 1994 |
| Metric | NTHI | ACU |
|---|---|---|
| Price | $4.27 | $43.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $15.00 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 51.0K | 17.9K |
| Earning Date | 05-19-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 1.63 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $196,541,816.00 |
| Revenue This Year | N/A | $5.67 |
| Revenue Next Year | N/A | $5.25 |
| P/E Ratio | ★ N/A | $181.42 |
| Revenue Growth | N/A | ★ 1.05 |
| 52 Week Low | $3.20 | $35.50 |
| 52 Week High | $12.99 | $47.31 |
| Indicator | NTHI | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 58.68 |
| Support Level | $3.87 | $43.07 |
| Resistance Level | $5.90 | $45.03 |
| Average True Range (ATR) | 0.42 | 1.31 |
| MACD | -0.04 | 0.29 |
| Stochastic Oscillator | 16.67 | 88.38 |
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.